Detalles de la búsqueda
1.
Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 73(3): 309-315, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30578152
2.
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 21(5): 1199-1208, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30672083
3.
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.
Am J Kidney Dis
; 70(4): 522-531, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28599901
4.
Race and ethnicity influences on cardiovascular and renal events in patients with diabetes mellitus.
Am Heart J
; 170(2): 322-9, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26299230
5.
Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 66(3): 429-40, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25935581
6.
Erythropoietic response and outcomes in kidney disease and type 2 diabetes.
N Engl J Med
; 363(12): 1146-55, 2010 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-20843249
7.
Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm.
Am J Kidney Dis
; 61(2): 238-46, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23159232
8.
Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience.
Circulation
; 124(25): 2903-8, 2011 Dec 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22104547
9.
A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease.
N Engl J Med
; 361(21): 2019-32, 2009 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-19880844
10.
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
Am Heart J
; 162(4): 748-755.e3, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21982669
11.
Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
Am J Kidney Dis
; 54(1): 59-69, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19501439
12.
2011 Burl Osborne Pioneer Organ Replacement Hero Award and the 2011 Osborne-IFAO prizes for outstanding scientific achievement.
Artif Organs
; 37(5): 421-2, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23607585
13.
Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).
J Am Heart Assoc
; 5(4)2016 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27108247
14.
Rationale--Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): evolving the management of cardiovascular risk in patients with chronic kidney disease.
Am Heart J
; 149(3): 408-13, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15864229
15.
Uncertainty in the treatment of anemia in chronic kidney disease.
Rev Cardiovasc Med
; 6 Suppl 3: S35-41, 2005.
Artículo
en Inglés
| MEDLINE | ID: mdl-16340937
16.
2009 Burl Osborne Pioneer Organ Replacement Hero Award and the 2009 Osborne-IFAO Prizes for Outstanding Scientific Achievement.
Artif Organs
; 33(12): 1045-7, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20078561
17.
2007 Burl Osborne Pioneer Organ Replacement Hero Award and the 2007 Burl Osborne Best Paper Award.
Artif Organs
; 32(2): 89-90, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18269351
18.
20 years since the establishment of the BANTAO association (Balkan Cities Association of Nephrology, Dialysis, Transplantation and Artificial Organs).
Pril (Makedon Akad Nauk Umet Odd Med Nauki)
; 34(2): 181-213, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-24280893
19.
The WAA. Message from the president.
Transfus Apher Sci
; 29(1): 99-100, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-12877900
20.
Vascular access and patient outcomes in hemodialysis: questions answered in recent literature.
Artif Organs
; 27(3): 237-41, 2003 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-12662209